INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

ABOSAcumen Pharmaceuticals, Inc.

CIK 0001576885

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 3
Max Insider Score30
Connections3with evidence

ABOS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
26
DJ
Doherty James J.President and CDO
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$3,379
1,700 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2836 · Biological Products, (No Diagnostic Substances) · Nov 5, 2026
  • ← Insider ofevidence
    Doherty James J.President and CDO · Jan 9, 2026
  • ← Insider ofevidence
    Schacterle AmyChief Regulatory Officer · Jan 9, 2026
26
DJ
Doherty James J.President and CDO
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL
$12K
6,467 sh
Jan 8, 2026
Jan 9, 2026
traded Jan 8, 2026
+1d
SEC FORM 4

Evidence

30
SA
Schacterle AmyChief Regulatory Officer
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$2,176
1,097 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence